R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2022
Back to search
Official data from USPTO
KANTARO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/08/2022
Trademark type
Word
Nice classes
5
Filing date
05/18/2020
Registration date
03/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2022
Last transaction
03/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/14/2020
First use in commerce
08/28/2020
Drawing code
4
Owner type
16
Owner location
New York, NY, US
Examiner
PURATH, ANICKA S
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kantaro Biosciences LLC
Representatives
Michelle A. Cooke MANATT, PHELPS & PHILLIPS, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical diagnostic reagents and assays for testing and analysis of bloodbodily fluidsbiological and cellular samples and specimens and tissue; Assaysreagentssolutionsbuffers and preparations for medicalclinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agentspreparationssubstances and diagnostic test kits primarily comprised of medical diagnostic reagents and assaysalso consisting of vesselscontainers and implements being medical specimen collection and processing devices in the nature of tubesswabsbagsvialslaboratory bottlescupslaboratory pipettes for the collection and processing of bloodbodily fluidsbiological and cellular samples and specimens and body tissue for performing serological and molecular testsused for detecting antibodiesenzymesantigensdiseasesviruses and infections for medicalclinical and research purposes; Test kits consisting of medical diagnostic reagentsassayssolutions and buffers for testing in the field of the prevention and treatment of infectionsvirusesdisorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bloodbodily fluidsbiological and cellular samples and specimens and tissue for use in infectionvirus and disease detectioninfectiousviralcommunicableblood borne pathogenvector bornepulmonaryrespiratoryinflammatoryimmunologicalautoimmunerheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical diagnostic test kits comprised of medical diagnostic assaysreagentsmediasolutions in the nature of reagent solutionssubstrate solutionsstop solutionsstaining solutionsstandard solutions and buffer solutionsbuffers and diagnostic preparations for coronavirusSARS-CoV-2 and COVID-19 diagnosis and monitoring
Publications
History of USPTO decisions and trademark events.
26 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/01/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/31/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/28/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/28/2022
IUAF
USE AMENDMENT FILED
01/13/2022
EISU
TEAS STATEMENT OF USE RECEIVED
01/13/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/13/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/18/2021
PUBO
PUBLISHED FOR OPPOSITION
05/18/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2021
DOCK
ASSIGNED TO EXAMINER
04/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/26/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2020
GNRT
NON-FINAL ACTION E-MAILED
11/08/2020
CNRT
NON-FINAL ACTION WRITTEN
11/08/2020
DOCK
ASSIGNED TO EXAMINER
11/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2020
NWAP
NEW APPLICATION ENTERED
05/21/2020
Continuous trademark protection
Get notified about every new filing that threatens KANTARO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.